Overview

Autologous Cardiac Stem Cell Injection in Patients With Hypoplastic Left Heart Syndrome: An Open Label Pilot Study.

Status:
Not yet recruiting

Trial end date:
2025-07-01

Target enrollment:

Participant gender:

Summary

Male or female neonates, < 28 days (inclusive) diagnosed with hypoplastic left heart syndrome (HLHS) undergoing Stage I surgery. A total of 30 patients will be enrolled for this pilot study in a staged enrollment diagnosed with HLHS.All patients will be followed for 12 months post-treatment.

Phase:

Phase 1

Details

Lead Sponsor:

Joshua M Hare

Collaborator:

University of Maryland